Crossmark

Elevated high-sensitivity C-reactive protein and dyslipidaemia in type 2 diabetes mellitus: implications for cardiovascular risk prediction in Nigerian patients

Crossref DOI link: https://doi.org/10.1186/s12902-025-01930-3

Published Online: 2025-04-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mohammed, Jamila Aminu

Basil, Bruno

Mba, Izuchukwu Nnachi

Abubakar, Nabilah Datti

Lawal, Akeem Oyeyemi

Momoh, Jafaru Alunua

Yahaya, Isah Adagiri
License Information

Text and Data Mining valid from 2025-04-17

Version of Record valid from 2025-04-17
More Information

Article History

Received: 24 August 2024

Accepted: 9 April 2025

First Online: 17 April 2025

Declarations

:

: This study was approved by the Health Research Ethics Committee of the National Hospital, Abuja with protocol number NHA/EC/076/2019 on 12th September 2019, and was conducted in compliance with the Declaration of Helsinki. Informed and written consent was obtained from all participants before inclusion in the study and data collection.

: Not Applicable in this study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below